Murat Hakan Kır

Dr. Murat Hakan Kır

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
MKMurat Hakan Kır
Murat Hakan Kır
ABAysun BENLİ
Aysun BENLİ
ZOZarifa Orta
Zarifa Orta
SBSeniha Başaran
Seniha Başaran
MOMerih Oray
Merih Oray
HÖHalit Özsüt
Halit Özsüt
Syphilis is a re-emerging sexually transmitted infection with rising incidence worldwide, often associated with HIV infection. Ocular syphilis represents a severe manifestation that can occur at any disease stage and may result in permanent vision loss if not promptly diagnosed and treated. We conducted a retrospective comparative cohort study of 22 patients with ocular syphilis managed at Istanbul University, Istanbul Faculty of Medicine, between 2019 and 2025. Twelve patients (54.5%) were people living with HIV (PLWH). The majority were male (81.8%), with a mean age of 45.2 years. Visual loss was observed in more than half of the patients and occurred significantly more frequently in PLWH than in HIV-negative individuals (100% vs. 70%; p = 0.046). Vitritis was also significantly more frequent among PLWH (91.7% vs. 40%; p = 0.02), indicating more severe intraocular inflammation. All six cases of neurosyphilis were confined to PLWH (50% vs. 0%; p = 0.004). The most common ocular manifestations were uveitis (90.9%), predominantly panuveitis and posterior uveitis. All patients received intravenous penicillin G or ceftriaxone, and systemic corticosteroids were administered in half of the cases. Clinical improvement was observed in all patients. Our findings highlight that ocular syphilis in PLWH is associated with more severe inflammation and higher neurosyphilis risk, underscoring the importance of routine cerebrospinal fluid examination and neurosyphilis-based treatment strategies in this group.

4 February 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
GYGizem Yapar
Gizem Yapar
MKMuammer Osman Köksal
Muammer Osman Köksal
Kutay SarsarKutay Sarsar
Kutay Sarsar
PSpınar soğuksu
pınar soğuksu
Mehmet DemirciMehmet Demirci
Mehmet Demirci
Hayriye Kırkoyun UysalHayriye Kırkoyun Uysal
Hayriye Kırkoyun Uysal
Background/Objectives: T. pallidum subsp. pallidum is a spirochete that only causes disease in humans as the causative agent of syphilis. HIV and syphilis have common transmission routes. In the present study, our aim was to evaluate the presence of syphilis coinfection in people living with HIV using conventional and reverse algorithms and to investigate its effects on laboratory parameters. Methods: The traditional algorithm for syphilis begins testing with the non-treponemal test. If the non-treponemal test is reactive, a treponemal test is then used to confirm syphilis infection. The reverse algorithm for syphilis begins testing with the treponemal test. If this test is reactive, then a non-treponemal test is performed. When the non-treponemal test is non-reactive, a second treponemal test is performed. Results: A total of 200 patients were included in the study. While 22 patients were determined to be syphilis-positive using the traditional algorithm, 37 patients were determined to be syphilis-positive using the reverse algorithm. Most of the patients who had syphilis coinfection were homosexual. Conclusions: It was found that syphilis coinfection had no effects on CD4+ T-lymphocyte and CD8+ T-lymphocyte values, CD4/CD8 rates, and HIV RNA amounts. People living with HIV must be screened and followed up for syphilis and other sexually transmitted diseases at certain intervals.

30 September 2026 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
EBElif Agüloğlu Bali
Elif Agüloğlu Bali
YCYasemin Cakir
Yasemin Cakir
IAİrEm Akdemir
İrEm Akdemir
EAEda ALP
Eda ALP
FBFeyza Nur Akçin Balan
Feyza Nur Akçin Balan
Onder ErgonulOnder Ergonul
Onder Ergonul
Artificial intelligence (AI) is increasingly influencing healthcare, with growing relevance in infectious diseases and clinical microbiology. This review summarizes current applications of machine learning (ML), deep learning (DL), and large language models (LLMs) in these areas while critically evaluating their strengths and limitations. Although AI has shown promising performance in image analysis, molecular diagnostics, risk prediction, and clinical decision support, its routine implementation remains constrained by limited external validation, heterogeneous datasets, algorithmic bias, and challenges in generalizability and explainability. The review also discusses AI’s emerging role in scientific writing and the ethical and practical considerations associated with its clinical adoption. Overall, current evidence suggests that AI should be regarded as a complementary decision-support technology whose safe and effective integration depends on rigorous validation, high-quality data, and appropriate clinical oversight.

27 April 2025 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
ZOZarifa Orta
Zarifa Orta
SASelva Ala-Selek
Selva Ala-Selek
MKMurat Hakan Kır
Murat Hakan Kır
ABAysun BENLİ
Aysun BENLİ
AÇArif Atahan Çağatay
Arif Atahan Çağatay

9 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
Arat HulikyanArat Hulikyan
Arat Hulikyan
Hayriye Kırkoyun UysalHayriye Kırkoyun Uysal
Hayriye Kırkoyun Uysal
GDGİZEM DAĞCI
GİZEM DAĞCI
BÇBilger Çavuş
Bilger Çavuş
SKSebahattin Kaymakoglu
Sebahattin Kaymakoglu
MOMustafa Onel
Mustafa Onel
Background/Objectives: Hepatitis B (HBV) and hepatitis C (HCV) coinfection leads to the progression of liver disease and results in clinically serious outcomes. Continuous monitoring of epidemiological data is crucial for managing the regional disease burden. This study investigates the current seroprevalence of HBV and HCV, the prevalence of coinfection, and the rates of active replication in Istanbul. Methods: This retrospective analysis included 7131 patients evaluated at the Infectious Diseases and Gastroenterohepatology clinics between 2021 and 2025. Initial serological screening for viral markers was performed using routine chemiluminescent immunoassays. Active viral replication was subsequently confirmed and quantified via real-time polymerase chain reaction (PCR). Results: Active HBV replication was significantly more frequent among patients in the Gastroenterohepatology clinic (20.47%) compared to those in Infectious Diseases (5.36%). Active HCV infections were rare in both departments (0.25% and 0.04%, respectively). Simultaneous HBV and HCV coinfection was detected in only 17 patients (0.24%). Demographic evaluation demonstrated that HBV marker positivity was more prevalent in male patients and individuals over 40 years of age. Conclusions: HBV seroprevalence remains substantially higher than HCV in this cohort. The high rate of active HBV replication in gastroenterohepatology settings indicates a concentrated burden of active disease in these specialized clinics. These distribution patterns emphasize the necessity of routine, targeted HBV screening for older male demographics to facilitate early clinical intervention.